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Abstract Friedreich ataxia is a recessively inherited neurode-
generative disease caused by deficiency of a highly conserved
mitochondrial protein, frataxin. Frataxin deficiency results in
mitochondrial iron accumulation and oxidative stress. Frataxin
shows homology with the CyaY proteins of Q-purple bacteria,
whose function is unknown. We knocked out the CyaY gene in
Escherichia coli MM383 by homologous recombination and we
generated an E. coli MM383 strain overexpressing CyaY.
Bacterial growth, iron content and survival after exposure to
H2O2 did not differ among these strains, suggesting that, despite
structural similarities, cyaY proteins in bacteria may have a
different function from frataxin homologues in mitochondria.
z 1999 Federation of European Biochemical Societies.
Key words: Friedreich ataxia; CyaY; Iron; Free radical ;
Hydrogen peroxide; Escherichia coli
1. Introduction
Friedreich ataxia (FRDA) is an autosomal recessive degen-
erative disease characterized by atrophy of long axonal tracts
in the spinal cord, large primary sensory neurons, cardiomyo-
cytes and possibly pancreas L-cells [1]. Patients develop ataxia
and hypertrophic cardiomyopathy, and are at high risk for
diabetes mellitus [2]. The disease is caused by a de¢ciency of
frataxin, a small mitochondrial protein (210 amino acids, 150
amino acids after mitochondrial import and removal of the N-
terminal targeting sequence) encoded by a gene on chromo-
some 9q13 [3]. Frataxin de¢ciency is in most cases consequent
on homozygosity for an expanded GAA triplet repeat in the
¢rst intron of the gene, occasionally on heterozygosity for a
GAA expansion and a point mutation [3]. The FRDA gene is
highly expressed in mitochondria-rich cells, particularly in
those a¡ected by the disease [4,5]. Though not resembling
any protein with known function, frataxin shows a remark-
able evolutionary conservation, with homologues in mam-
mals, Caenorhabditis elegans, and yeast. Knock-out of the
yeast homolog gene (YFH1) results in a 10-fold increase of
mitochondrial iron, increased sensitivity to oxidants, and
eventually in loss of mitochondrial DNA and a petite pheno-
type [6^8]. Together with preliminary evidence that iron me-
tabolism is altered in the human disease, including the pres-
ence of iron deposits in the myocardium of a¡ected individu-
als [9], these ¢ndings indicate that frataxin has a role in
controlling mitochondrial iron homeostasis, probably by stim-
ulating the e¥ux of iron out of these organelles [10]. The most
conserved portion of frataxin also has a signi¢cant similarity
to the cyaY proteins of Q-purple bacteria, whose function is
unknown (Fig. 1). In enterobacteria, the cyaY gene is local-
ized near the gene encoding adenylyl cyclase (cya), hence its
name, before the downstream dapF gene [11]. Its open reading
frame (ORF) is in the complementary strand with respect to
cya. A 335 to 310 promoter region, similar to c70 pro-
moters, precedes the cyaY gene, followed by a consensus ri-
bosome-binding sequence (Shine-Dalgarno) before the start
codon [11]. Therefore, cyaY has its own transcription and
translation control region, independent of cya. Fusion con-
structs in which the cyaY promoter was inserted upstream
of the lacZ gene permitted expression of a signi¢cant amount
of L-galactosidase, indicating that this gene is expressed in
Escherichia coli [11]. The sequence similarity between cyaY
and frataxin was one of the ¢rst clues of the mitochondrial
localization of frataxin, as Q-purple bacteria are related to the
ancestor of mitochondria [12]. CyaY proteins are not found in
bacteria thought to be unrelated to the ancestor of mitochon-
dria, such as Gram-positive species, while Rickettsia prowa-
zeckii, possibly the closest living species to the ancestor of
mitochondria, has the cyaY gene with highest similarity to
the eukaryotic frataxin homologs [13]. It was proposed that
eukaryotic frataxin homologs and cyaY proteins form a fam-
ily of proteins sharing a structural domain which is conserved
from bacteria to mammals [12]. In order to investigate
whether this conserved structure is also re£ected in a con-
served function, namely control of intracellular or intramito-
chondrial iron concentration and sensitivity to oxidative
stress, we knocked out the E. coli cyaY gene by homologous
recombination and evaluated the growth properties, iron con-
tent and sensitivity to H2O2 of cyaY3 bacteria compared to a
wild-type and a cyaY-overexpressing strain.
2. Materials and methods
2.1. Bacterial strains
E. coli DH5K was used as a temporary host during plasmid con-
struction. E. coli MM383 was obtained from the E. coli Genetic Stock
Center of Yale University, This strain has a temperature-sensitive
DNA polymerase I (polA gene) and is totally defective in nick trans-
lation at 42‡C.
0014-5793 / 99 / $20.00 ß 1999 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 9 ) 0 0 8 9 6 - 0
*Corresponding author. Fax: (1) (514) 896-4762.
E-mail: massimo.pandolfo@umontreal.ca
FEBS 22346 23-7-99
FEBS 22346 FEBS Letters 456 (1999) 13^16
2.2. DNA manipulations and bacterial cultures
Preparation of chromosomal or plasmid DNA from bacteria, bac-
terial transformations (except when using the MM383 strain), DNA
ampli¢cation by PCR, electrophoresis, restriction enzyme digestions,
DNA ligation, DNA sequencing, were all performed according to
standard protocols [14]. Because of their polA temperature-sensitive
mutation, E. coli MM383 were grown at 30‡C and heat shocked at
37‡C for transformation. LB and minimal medium were prepared
according to standard protocols. MM383 and derived strains need
the addition of thymine to grow in minimal medium.
2.3. Construction of a cyaY-overexpressing MM383 derivative (Bfh2)
pOSEX4 was used as plasmid expression vector (a kind gift
from Dr. E. Bremer). The cyaY gene was ampli¢ed from E. coli
chromosomal DNA using the primers cyaY1-F (5P- TTGGATCCT-
TAACACAGGAAACAGACCATGAACGACAGTGAATTTCAT-
3P) and cyaY2-R (5P-AAAGGTACCTTAGCGGAAACTGACTGT-
T-3P), which generate an ampli¢ed fragment with a BamHI site at
the 5P end of the gene and a KpnI site at the 3P end of the gene.
The fragment was then ligated into pOSEX4 at the BamHI/KpnI
cloning site forming pMP501, which was then used to transform
MM383, obtaining the cyaY-overexpressing Bfh2 strain.
2.4. Knock-out of cyaY in MM383 by homologous recombination to
obtain the Bfh1 strain
CyaY was disrupted by the insertion of a kanamycin resistance gene
(kanr) essentially as described by Gutterson and Koshland [15]. Two
fragments corresponding to sequences £anking the cyaY gene were
ampli¢ed from E. coli MM383 chromosomal DNA. The upstream
£ank, UF, was ampli¢ed using the UF1-F (5P-GCACCGTGGAT-
TGCGTTTGCGTCT-3P) and UF2-R (5P-TCGCTGTCGACATCC-
CAGTCGTCCA-3P) primers. The downstream £ank, DF, was ampli-
¢ed using the DF1-F (5P- GGATTTGCTGGAACAGGCGTCGAC-
3P) and DF2-R (5P-TTGCGGGAATTCAACCGGCACATCT-3P)
primers. These primers contain the underlined restriction sites, SalI
for UF2-R, EcoRI for DF2-F and DF2-R. UF and DF were digested
by SalI, ligated to each other and inserted into EcoRI/PstI-digested
pUC18, obtaining pMP502. A kanamycin resistance gene (kanr) from
pUC4K was inserted at the SalI site between UF and DF forming
pMP503. The whole UF-kan-DF fragment was then excised from
pUC18 using EcoRI and PvuII and inserted into EcoRI/MscI-digested
pBR322, obtaining pMP504 (Fig. 1). pMP504 was used to transform
MM383 at 30‡C and a colony from the above transformant was
grown in LB with streptomycin (50 Wg/ml) and kanamycin (50 Wg/
ml) overnight at 42‡C to promote plasmid integration. About 200 Wl
of the above culture were grown in LB with only streptomycin at 30‡C
for 3^4 h to eliminate episomal plasmids, then the temperature was
switched back to 42‡C and kanamycin was added to select for cells
with an integrated kanr gene. An aliquot of the culture was plated on
streptomycin, 96 colonies were picked and separately tested for kana-
mycin and ampicillin resistance. The two colonies resistant to kana-
mycin but not to ampicillin had an integrated kanr gene but no
pBR322 sequences, so they were expected to have a disrupted cyaY
gene (Fig. 2). PCR analysis con¢rmed that the cyaY gene in these cells
had been disrupted by the replacement of most of its coding sequence
with a kanr gene (Fig. 3).
2.5. Iron concentration assays
Bacteria were grown in 20 ml of LB, either with no iron supplement
or with a supplement of 10, 30, 100, 1000 or 3000 Wg/ml FAC (ferric
ammonium citrate, Fisher, USA), at 37‡C for about 11 h with vigo-
rous shaking (300 rpm). The cells were washed four times with
1Ufresh LB medium, twice with 10 ml and twice with 1 ml, and their
OD600 was determined. Six iron determinations were obtained for
each sample using a Perkin Elmer Optima 3100XL instrument (induc-
tively coupled plasma optical emission spectroscopy) in which each
sample was run in duplicate on three dedicated lines. Iron concentra-
tions were expressed as nmol/109 cells.
2.6. H2O2 sensitivity assays
Bacteria were grown in LB with vigorous shaking (300 rpm) at
37‡C to a density of 0.8U107 to 2U107 cells/ml and then challenged
with 0.5 mM H2O2 (Sigma) in 1 ml of LB for 10 min. The challenge
was terminated by diluting the culture 60 times with LB. For survival
studies, cells were plated in top agar and colonies were counted after
24^36 h.
Fig. 1. Multiple sequence alignment (ClustalW 1.74) of human, mouse, C. elegans, Saccharomyces cerevisiae frataxin homologs and E. coli and
R. prowazeckii cyaY proteins. Homology between the eukaryotic and the prokaryotic proteins begins after the N-terminal portion of the eu-
karyotic proteins containing the mitochondrial targeting sequence.
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3. Results and discussion
The cyaY gene of E. coli MM383 was disrupted by substi-
tuting most of its open reading frame with a kanr gene. The
temperature-sensitive polA mutation of MM383 was exploited
to insert a pBR322-derived plasmid carrying a disrupted cyaY
gene into chromosomal DNA by homologous recombination,
then to excise the plasmid leaving a disrupted chromosomal
copy of cyaY (Fig. 2). vcyaY bacteria (Bfh1) were selected for
kanamycin resistance and ampicillin sensitivity. Conversely, a
cyaY-overexpressing strain (Bfh2) was obtained by cloning the
cyaY open reading frame into the pOSEX4 expression vector
and using the resulting pMP501 plasmid to transform
MM383. Wild-type MM383, Bfh1 and Bfh2 did not show
di¡erential growth either in LB or in minimal medium+thy-
mine, and formed colonies of identical morphology. Wild-type
and Bfh1 cells were grown for 11 h in LB medium supple-
mented with various amounts of iron (as FAC), in which they
grew equally well. When iron content was determined by in-
ductively coupled plasma optical emission spectroscopy, it
was found not to di¡er between the two strains, which were
both able to maintain iron homeostasis (Fig. 3). Exposure to a
low dose of H2O2 equally reduced the survival of wild-type
MM383 and of Bfh1 and Bfh2 (Fig. 4).
From the above results, it can be concluded that, at least in
the tested conditions, cyaY a¡ects neither intracellular iron
Fig. 2. Upper panel: PCR analysis showing a disrupted cyaY gene
in Bfh1. The cyaY gene was ampli¢ed by PCR using the cyaY1-F
and cyay2-R primers. In wild-type MM383 (lane 5) the resulting
fragment has a size of 0.33 kb; in Bfh1 (lanes 3 and 4) the fragment
has a size of 1.35 kb because of the insertion of the Kanr gene (1.25
kb) and the loss of cyaY sequence. Lane 1: molecular size markers
(1 kb ladder); lane 2: blank. Lower panel: Scheme of the replace-
ment of the segment of chromosomal DNA containing the cyaY
gene by the homologous sequence in the plasmid.
Fig. 3. Intracellular iron in wild-type MM383 and Bhf1 E. coli after
11 h of growth in LB medium supplemented with the indicated
amounts of iron (as ferric ammonium citrate).
Fig. 4. Percent survival of wild-type MM383, Bhf1 and Bhf2 E. coli
after a 10 min exposure to 0.5 mM H2O2.
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content nor resistance to exogenous oxidants such as H2O2.
Considering that no di¡erence in growth rate or in colony
morphology was found between wild-type, vcyaY3 and
cyaY-overexpressing bacteria, either in rich medium (LB) or
in minimal medium, the function of this protein remains ob-
scure. Consequently, a disappointing aspect of our ¢ndings is
that it does not seem possible to exploit the simple genetics of
bacteria to obtain data relevant to frataxin function.
Structurally, the similarity between cyaY proteins and the
mature intramitochondrial forms of eukaryotic frataxin ho-
mologs remains remarkable. The similarity in amino acid se-
quence is highly signi¢cant, and the predicted structure is
essentially the same: a central L-sheet region spanning the
most conserved domain, £anked by two K-helices [12]. How-
ever, the di¡erence of function between cyaY and the eukary-
otic frataxin homologs does not come completely as a sur-
prise, because there are many examples of proteins with an
overall conserved structure but a modi¢ed function during
evolution. The small size of both mature frataxin and cyaY
makes it unlikely that these proteins have enzymatic activity.
Accordingly, it has been proposed that they may act as regu-
lators or metabolite carriers [12]. The yeast frataxin homolog
(yfh1p) is likely to stimulate the out£ow of non-heme iron
from mitochondria [10], a function that is fully compatible
with a regulator or metabolite carrier role. Bacterial cyaY
proteins may have a similar function, except that the carrier
system they activate or the metabolite they bind does not
a¡ect iron homeostasis. It is somewhat surprising that cyaY
knockout has no evident e¡ect on bacterial viability, consid-
ering how conserved cyaY proteins are among purple bacteria.
The fact that a cyaY gene is present in R. prowazeckii [13]
despite the reduction that the genome of this intracellular
parasite has undergone would point to a more essential func-
tion. Perhaps this gene has acquired a new function with the
passage to intracellular life, related to metabolic exchanges
with the host cell, as has happened for the mitochondria pre-
cursor.
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